Roche raises guidance on forecast-beating nine-month sales

Core Insights - Swiss drugmaker Roche has raised its full-year guidance following better-than-expected nine-month sales [1] Company Summary - Roche reported nine-month sales that exceeded expectations, prompting the company to adjust its full-year outlook positively [1]